Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply
| Errataetall: |
CommentOn: Lancet HIV. 2022 Jul;9(7):e474-e485. - PMID 35688166 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
The lancet. HIV - 10(2023), 1 vom: 15. Jan., Seite e9-e10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Neesgaard, Bastian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.12.2022 Date Revised 23.02.2023 published: Print CommentOn: Lancet HIV. 2022 Jul;9(7):e474-e485. - PMID 35688166 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S2352-3018(22)00367-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350775796 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350775796 | ||
| 003 | DE-627 | ||
| 005 | 20231226045747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2352-3018(22)00367-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM350775796 | ||
| 035 | |a (NLM)36566083 | ||
| 035 | |a (PII)S2352-3018(22)00367-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Neesgaard, Bastian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tenofovir disoproxil fumarate withdrawal and cardiovascular risk - Authors' reply |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.12.2022 | ||
| 500 | |a Date Revised 23.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Lancet HIV. 2022 Jul;9(7):e474-e485. - PMID 35688166 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Tenofovir |2 NLM | |
| 650 | 7 | |a 99YXE507IL |2 NLM | |
| 650 | 7 | |a Anti-HIV Agents |2 NLM | |
| 700 | 1 | |a Greenberg, Lauren |e verfasserin |4 aut | |
| 700 | 1 | |a Peters, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Mocroft, Amanda |e verfasserin |4 aut | |
| 700 | 1 | |a Ryom, Lene |e verfasserin |4 aut | |
| 700 | 0 | |a writing group and the RESPOND study group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. HIV |d 2014 |g 10(2023), 1 vom: 15. Jan., Seite e9-e10 |w (DE-627)NLM244270694 |x 2352-3018 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:1 |g day:15 |g month:01 |g pages:e9-e10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2352-3018(22)00367-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |e 1 |b 15 |c 01 |h e9-e10 | ||